Momenta Pharmaceuticals Inc (NASDAQ:MNTA)
| 11.08 Data as of Jul 30 |  +0.12 / +1.09%Today’s Change | 9.85 Today|||52-Week Range 19.90 | -37.33% Year-to-Date |
Latest MNTA News | Press Releases
No recent news for Momenta Pharmaceuticals Inc.
Today’s Trading
| Previous close | 10.96 |
| Today’s open | 11.06 |
| Day’s range | 10.96 - 11.19 |
| Volume | 360,474 |
| Average volume (3 months) | 637,589 |
| Market cap | $578.1M |
| Dividend yield | -- |
Data as of 3:59pm ET, 07/30/2014
Growth & Valuation
| Earnings growth (last year) | -83.62% |
| Earnings growth (this year) | +145.70% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -44.52% |
| P/E ratio | NM |
| Price/Sales | 25.38 |
| Price/Book | 2.13 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ONVOOrganovo Holdings In... | +0.21 | +2.75% |
| OSIROsiris Therapeutics ... | -0.36 | -2.41% |
| FMIFoundation Medicine ... | -0.59 | -2.47% |
| HPTXHyperion Therapeutic... | -0.02 | -0.09% |
Data as of 4:00pm ET, 07/30/2014
Financials
| Last reporting date | July 31, 2014 |
| EPS forecast (this quarter) | -$0.47 |
| Annual revenue (last year) | $35.5M |
| Annual profit (last year) | -$108.4M |
| Net profit margin | -305.68% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Craig A. Wheeler |
Chief Financial Officer, Director & Senior VP Richard P. Shea |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
.
